• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种具有选择性特异性的抗C3单克隆抗体的特性分析。

Characterization of three monoclonal antibodies against C3 with selective specificities.

作者信息

Iida K, Mitomo K, Fujita T, Tamura N

机构信息

Department of Immunology, University of Tsukuba, Ibaraki, Japan.

出版信息

Immunology. 1987 Nov;62(3):413-7.

PMID:2444528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1454137/
Abstract

We raised 15 mouse monoclonal antibodies against human C3 from two separate fusions. Mouse plasmacytoma cells were fused with spleen cells from mice immunized either with a mixture of C3, C3b and C3c, or with a mixture of C3dg and C3d. Three of the 15 monoclonals were characterized in detail. N-7A reacted with native C3 as well as C3b and C3c. Two other monoclonals, C-5G and G-3E, recognized neoantigenic determinants on C3c and C3dg, respectively. In ELISA, C-5G reacted with C3b and C3c but not with native C3 nor with C3dg; and on the other hand G-3E reacted only with C3dg. The selective specificities of these monoclonals were further confirmed in a binding assay to C3 fragments formed on cellular intermediates. C-5G bound exclusively to EC3b, and G-3E bound to EiC3b, EC3dg and EC3d. N-7A bound only very poorly to EC3b. C-5G inhibited both the haemolytic activity of C5 convertase and also the CR1-mediated rosette formation of B-enriched peripheral mononuclear cells with EC3b. G-3E inhibited the CR2-mediated EC3dg-rosette formation of Raji cells. These monoclonals, with selective specificities, can distinguish the state of activation and degradation of the C3 molecule.

摘要

我们通过两次独立的融合制备了15种抗人C3的小鼠单克隆抗体。将小鼠浆细胞瘤细胞与用C3、C3b和C3c混合物或C3dg和C3d混合物免疫的小鼠脾细胞进行融合。对这15种单克隆抗体中的3种进行了详细表征。N-7A与天然C3以及C3b和C3c反应。另外两种单克隆抗体C-5G和G-3E分别识别C3c和C3dg上的新抗原决定簇。在酶联免疫吸附测定(ELISA)中,C-5G与C3b和C3c反应,但不与天然C3或C3dg反应;另一方面,G-3E仅与C3dg反应。这些单克隆抗体的选择性特异性在与细胞中间体上形成的C3片段的结合试验中得到进一步证实。C-5G仅与EC3b结合,G-3E与EiC3b、EC3dg和EC3d结合。N-7A与EC3b的结合非常弱。C-5G既抑制C5转化酶的溶血活性,也抑制富含B细胞的外周单核细胞与EC3b的CR1介导的玫瑰花结形成。G-3E抑制Raji细胞的CR2介导的EC3dg玫瑰花结形成。这些具有选择性特异性的单克隆抗体可以区分C3分子的激活和降解状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1454137/1503219bb2ba/immunology00164-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1454137/1503219bb2ba/immunology00164-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1454137/1503219bb2ba/immunology00164-0076-a.jpg

相似文献

1
Characterization of three monoclonal antibodies against C3 with selective specificities.三种具有选择性特异性的抗C3单克隆抗体的特性分析。
Immunology. 1987 Nov;62(3):413-7.
2
gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).gp140是淋巴细胞的一种C3b结合膜成分,是B细胞C3dg/C3d受体(CR2),与中性粒细胞C3dg受体(CR4)不同。
Eur J Immunol. 1985 Dec;15(12):1192-7. doi: 10.1002/eji.1830151210.
3
Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.通过单克隆抗体检测人C3bi和C3d上的新抗原。
J Immunol. 1985 Sep;135(3):2015-9.
4
C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.人类淋巴细胞亚群上的C3受体以及C3片段对ADCC效应细胞的募集作用。
J Immunol. 1983 Jun;130(6):2831-6.
5
Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.补体C3序列中跨越第727至768位残基的片段包含一个新抗原位点,并可容纳补体受体1(CR1)、H因子和B因子的结合。
Biochemistry. 1992 Feb 18;31(6):1787-94. doi: 10.1021/bi00121a029.
6
Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.C3和C3dg与CR2补体受体的结合可诱导爱泼斯坦-巴尔病毒阳性人类B细胞系生长。
J Immunol. 1988 Jan 1;140(1):170-5.
7
Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.淋巴细胞和吞噬细胞上C3受体反应性的定性和定量评估。
J Immunol. 1981 May;126(5):2042-7.
8
Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.用于检测免疫复合物和补体激活的抗补体3新抗原单克隆抗体。免疫复合物水平、C3状态与C3b受体数量之间的关系。
J Clin Invest. 1985 Oct;76(4):1418-26. doi: 10.1172/JCI112119.
9
Three rat monoclonal antibodies to human C3.三种针对人C3的大鼠单克隆抗体。
Immunology. 1980 Nov;41(3):503-15.
10
Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.补体第三成分(C3)内部硫酯键的断裂导致新决定簇暴露,这些新决定簇也存在于C3的活化产物上。用单克隆抗体进行分析。
J Immunol. 1988 Sep 1;141(5):1602-9.

引用本文的文献

1
Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury.利用药物疗法和间充质干细胞疗法减轻创伤性脑损伤后的炎症。
Neural Regen Res. 2016 Sep;11(9):1379-1384. doi: 10.4103/1673-5374.191197.
2
Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.不可分型流感嗜血杆菌对经典和替代补体途径的抗性需要外膜蛋白P5。
Infect Immun. 2014 Feb;82(2):640-9. doi: 10.1128/IAI.01224-13. Epub 2013 Nov 25.
3
The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.

本文引用的文献

1
Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.系统性红斑狼疮患者红细胞中的补体受体(CR1)缺陷。
J Exp Med. 1982 May 1;155(5):1427-38. doi: 10.1084/jem.155.5.1427.
2
Evidence for presence of an internal thiolester bond in third component of human complement.人补体第三成分中存在内部硫酯键的证据。
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764-8. doi: 10.1073/pnas.77.10.5764.
3
Selective inhibition of functional sites of cell-bound C3b by hybridoma-derived antibodies.杂交瘤衍生抗体对细胞结合的C3b功能位点的选择性抑制。
在脑膜炎奈瑟菌上,补体替代途径调控中因子 H 结合蛋白、奈瑟菌表面蛋白 A 和脂寡糖唾液酸化的相对作用。
J Immunol. 2012 May 15;188(10):5063-72. doi: 10.4049/jimmunol.1103748. Epub 2012 Apr 13.
4
ArcA-regulated glycosyltransferase lic2B promotes complement evasion and pathogenesis of nontypeable Haemophilus influenzae.ArcA 调控的糖基转移酶 lic2B 促进了不可分型流感嗜血杆菌的补体逃避和发病机制。
Infect Immun. 2011 May;79(5):1971-83. doi: 10.1128/IAI.01269-10. Epub 2011 Feb 28.
5
Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.脑膜炎奈瑟菌 W-135 群和 Y 荚膜多糖出人意料地增强补体替代途径的激活。
J Biol Chem. 2011 Mar 11;286(10):8297-8307. doi: 10.1074/jbc.M110.184838. Epub 2011 Jan 18.
6
Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization.依库珠单抗可预防阵发性睡眠性血红蛋白尿症患者的血管内溶血,并通过 C3 调理作用揭示低水平的血管外溶血。
Haematologica. 2010 Apr;95(4):567-73. doi: 10.3324/haematol.2009.007229. Epub 2010 Feb 9.
7
Defining targets for complement components C4b and C3b on the pathogenic neisseriae.确定致病性奈瑟菌上补体成分C4b和C3b的靶点。
Infect Immun. 2008 Jan;76(1):339-50. doi: 10.1128/IAI.00613-07. Epub 2007 Nov 5.
8
Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.通过恢复不可分型流感嗜血杆菌siaB突变体的毒力揭示补体在中耳防御中的作用
Infect Immun. 2007 Jan;75(1):325-33. doi: 10.1128/IAI.01054-06. Epub 2006 Nov 6.
9
CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells.淋病菌IV型菌毛及主要菌毛黏附素PilC与人类上皮细胞的CD46非依赖性结合
Infect Immun. 2005 May;73(5):3072-82. doi: 10.1128/IAI.73.5.3072-3082.2005.
10
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.补体受体2介导的补体抑制剂靶向作用于补体激活部位。
J Clin Invest. 2003 Jun;111(12):1875-85. doi: 10.1172/JCI17348.
J Immunol. 1982 Jan;128(1):512-4.
4
Complement receptor is an inhibitor of the complement cascade.补体受体是补体级联反应的一种抑制剂。
J Exp Med. 1981 May 1;153(5):1138-50. doi: 10.1084/jem.153.5.1138.
5
Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.补体C3中假定硫酯键与替代途径激活及C3b与补体生物学靶点结合的关系。
J Exp Med. 1980 Oct 1;152(4):1102-14. doi: 10.1084/jem.152.4.1102.
6
Purification of the human complement control protein C3b inactivator.人补体调节蛋白C3b灭活剂的纯化
Biochem J. 1980 Oct 1;191(1):173-82. doi: 10.1042/bj1910173.
7
Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.利用单克隆抗体鉴定补体片段C3d的膜受体。
J Exp Med. 1983 Oct 1;158(4):1021-33. doi: 10.1084/jem.158.4.1021.
8
Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.利用单克隆抗体鉴定补体成分C3上的功能相关决定簇。
J Immunol. 1982 Nov;129(5):2042-50.
9
Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.补体激活后C3的分解。利用单克隆抗体鉴定一种新的片段C3g。
J Exp Med. 1982 Jul 1;156(1):205-16. doi: 10.1084/jem.156.1.205.
10
Three rat monoclonal antibodies to human C3.三种针对人C3的大鼠单克隆抗体。
Immunology. 1980 Nov;41(3):503-15.